Fewer Observations, Shift In Emphasis Seen In FDA's Pandemic-Reduced Inspections

 
• By Bowman Cox
  
Inspector in plant
fda investigators observed some issues during the pandemic • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance